Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinshuibao Capsule for Rehabilitation of COVID-19 Convalescent Patients
ChiCTR2100050587Phase 4Completed
- Sponsor
- Hubei Provincial Traditional Chinese Medical Hospital
- Start
- Apr 2020
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Jinshuibao capsule with Placebo (2 arms). Primary endpoints: Shortness of breath severity, Hyperhidrosis severity and 3 more. Started Apr 2020; status: completed.
02
Drugs
fermented cordyceps sinensis mycelia powder
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2100050587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050587.